ARP-1 Inhibitors
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $132.00 $1064.00 | 115 | |
Bortezomib is a proteasome inhibitor that directly impacts ARP-1 by inhibiting proteasomal degradation. ARP-1, being a substrate of the proteasome, undergoes degradation, and Bortezomib disrupts this process, leading to increased ARP-1 levels. | ||||||
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $56.00 $260.00 $980.00 | 163 | |
MG-132, another proteasome inhibitor, acts similarly to Bortezomib by preventing the degradation of ARP-1 through proteasomal inhibition. By stabilizing ARP-1 levels, MG-132 indirectly influences cellular processes where ARP-1 plays a role. | ||||||
Carfilzomib | 868540-17-4 | sc-396755 | 5 mg | $40.00 | ||
Carfilzomib, a selective proteasome inhibitor, directly targets ARP-1 by preventing its degradation via the proteasome. The accumulation of ARP-1 induced by Carfilzomib can modulate cellular processes where ARP-1 is involved. | ||||||
Geldanamycin | 30562-34-6 | sc-200617B sc-200617C sc-200617 sc-200617A | 100 µg 500 µg 1 mg 5 mg | $38.00 $58.00 $102.00 $202.00 | 8 | |
Geldanamycin is an Hsp90 inhibitor that indirectly influences ARP-1 stability. ARP-1 is known to interact with Hsp90, and Geldanamycin disrupts this interaction, leading to ARP-1 degradation. The modulation of ARP-1 levels by Geldanamycin can impact cellular processes related to ARP-1 functions. | ||||||
17-AAG | 75747-14-7 | sc-200641 sc-200641A | 1 mg 5 mg | $66.00 $153.00 | 16 | |
17-AAG, an Hsp90 inhibitor similar to Geldanamycin, indirectly modulates ARP-1 by disrupting its interaction with Hsp90, leading to ARP-1 degradation. The influence on ARP-1 levels by 17-AAG can affect cellular processes where ARP-1 plays a role. | ||||||
Heat Shock Protein Inhibitor I | 218924-25-5 | sc-221709 | 5 mg | $95.00 | 5 | |
Heat Shock Protein Inhibitor I (KNK437), a selective Hsp70 inhibitor, indirectly influences ARP-1 stability by affecting Hsp70-mediated processes. ARP-1 is known to interact with Hsp70, and the disruption of this interaction by KNK437 may lead to alterations in ARP-1 levels, influencing cellular processes where ARP-1 is involved. | ||||||
Withaferin A | 5119-48-2 | sc-200381 sc-200381A sc-200381B sc-200381C | 1 mg 10 mg 100 mg 1 g | $127.00 $572.00 $4090.00 $20104.00 | 20 | |
Withaferin A, a natural compound, indirectly modulates ARP-1 by affecting its interaction with Hsp90. The disruption of the ARP-1-Hsp90 interaction by Withaferin A may lead to ARP-1 degradation, influencing cellular processes where ARP-1 plays a role. | ||||||
Celastrol, Celastrus scandens | 34157-83-0 | sc-202534 | 10 mg | $155.00 | 6 | |
Celastrol, a natural compound, indirectly impacts ARP-1 by modulating Hsp90-mediated processes. ARP-1 interacts with Hsp90, and Celastrol disrupts this interaction, leading to ARP-1 degradation. The modulation of ARP-1 levels by Celastrol can affect cellular processes where ARP-1 plays a role. | ||||||
2-Deoxy-D-glucose | 154-17-6 | sc-202010 sc-202010A | 1 g 5 g | $65.00 $210.00 | 26 | |
2-Deoxyglucose (2-DG) indirectly influences ARP-1 by targeting glycolytic pathways. ARP-1, being sensitive to metabolic changes, may be affected by 2-DG-induced alterations in glycolysis, leading to changes in ARP-1 levels and cellular processes where ARP-1 is involved. | ||||||
NVP-AUY922 | 747412-49-3 | sc-364551 sc-364551A sc-364551B sc-364551C sc-364551D sc-364551E | 5 mg 25 mg 100 mg 250 mg 1 g 5 g | $150.00 $263.00 $726.00 $1400.00 $2900.00 $11000.00 | 3 | |
AUY922 is an Hsp90 inhibitor that indirectly modulates ARP-1 by disrupting its interaction with Hsp90. The resulting degradation of ARP-1 induced by AUY922 can influence cellular processes where ARP-1 plays a role. | ||||||